• $15.2M
    Market Cap
  • -47.17%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
0
-100.00%
269,000
N/A
Cost of Revenue
684,000
-64.69%
1.9M
N/A
Gross Profit
-684,000
-58.99%
-1.7M
N/A
Sales and Marketing Expense
10.6M
+51.48%
7.0M
N/A
Research and Development Expense
-10.6M
+129.59%
-4.6M
N/A
Depreciation and Amortization Expense
970,000
+31.08%
740,000
N/A
Total Operating Expenses
21.9M
-65.11%
62.7M
N/A
Operating Profit
-21.9M
-64.96%
-62.5M
N/A
Interest Income
477,000
+13.57%
420,000
N/A
Interest Expense
-2.9M
N/A
0
N/A
Interest Income and Expense and Net
-2.4M
-676.90%
420,000
N/A
Total Nonoperating Income and Expense
-3.2M
-136.64%
8.7M
N/A
Income before Taxes
-21.9M
-64.96%
-62.5M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-25.2M
-53.16%
-53.8M
N/A
Net Income from Continuing Operations Applicable to Common
-25.1M
-53.34%
-53.8M
N/A
Basic EPS and Net Income
-1.51
-55.33%
-3.38
N/A
Diluted EPS and Net Income
-1.51
-59.19%
-3.70
N/A
Basic Weighted Average Shares
16.6M
+12.21%
14.8M
N/A
Diluted Weighted Average Shares
16.6M
+12.21%
14.8M
N/A
Balance Sheet
Cash and Cash Equivalents
17.1M
-16.91%
20.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
17.1M
-16.91%
20.6M
N/A
Total Current Assets
20.1M
-20.78%
25.3M
N/A
Accumulated Depreciation
2.6M
-2.97%
2.7M
N/A
Property and Plant and Equipment and Net
1.5M
-21.72%
2.0M
N/A
Total Long-Term Assets
3,000
-78.57%
14,000
N/A
Total Assets
43.3M
-10.72%
48.4M
N/A
Income Taxes Payable
883,000
0.00%
883,000
N/A
Total Short-Term Debt
7.0M
-19.49%
8.7M
N/A
Total Current Liabilities
8.2M
+6.05%
7.8M
N/A
Total Long-Term Debt
21.0M
+29.72%
16.2M
N/A
Total Long-Term Liabilities
3.6M
0.00%
3.6M
N/A
Total Liabilities
30.9M
+8.11%
28.5M
N/A
Retained Earnings
-95.6M
+35.45%
-70.6M
N/A
Total Stockholders Equity
12.4M
-37.72%
19.9M
N/A
Total Shares Outstanding
22.2M
+46.14%
15.2M
N/A
Cash Flow
Cash from Operating Activities
-19.0M
+41.17%
-13.5M
N/A
Capital Expenditures
374,000
-70.78%
1.3M
N/A
Cash from Investing Activities
-374,000
-70.78%
-1.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
16.1M
+3.20%
15.6M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-54.93%
N/A
N/A
N/A
Return on Equity
-155.87%
N/A
N/A
N/A
Revenue Growth
-100.00%
N/A
N/A
N/A
Current Ratio
2.44
N/A
N/A
N/A
Cash Ratio
2.08
N/A
N/A
N/A
Debt-to-Equity Ratio
2.26
N/A
N/A
N/A
Debt-to-Assets Ratio
0.65
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow